Activation of glucagon-like peptide-1 receptor in microglia attenuates neuroinflammation-induced glial scarring via rescuing Arf and Rho GAP adapter protein 3 expressions after nerve injury
There is no known treatment for the condition, which affects 10 out of 100,000 people in the general population
These side effects generally dissipate within the first few weeks of treatment
Some people find they can reduce their dose over time while maintaining their weight loss, which lowers both cost and side effect burden
Look AHEADR, Group, Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, et al
and published via PubMed, outlines a staged approach based on age, BMI severity, and response to behavioral interventions